GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.

Guizhou Xinbang Pharmaceutical Co., Ltd.

002390

CNE100000NG5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
4.02 ^CNY	-0.74%		+1.52%	-9.46%

04-28	Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.

June 26, 2023

The Board of Directors of Guizhou Xinbang Pharmaceutical Co., Ltd. has authorized a buyback plan on June 27, 2023.

Latest news about Guizhou Xinbang Pharmaceutical Co., Ltd.

Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-15	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	04-01	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Board Appointments	02-21	CI
Xinbang Pharma Chairman Buys 14 Million Yuan More Shares	01-04	MT
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	01-03	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	09/10/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. commences an Equity Buyback Plan for 14,705,882 shares, representing 0.76% for CNY 200 million, under the authorization approved on July 13, 2023.	14/07/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	26/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component Index	09/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component A Share Index	09/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023	24/05/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Final Dividend for 2022	15/05/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022	18/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividend for 2021, Payable on 24 May 2022	18/05/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend	09/05/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Proposal for 2021	15/04/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	14/04/22	CI

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

Duration

Period

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

More charts

GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.	-9.46%	1.07B
DONG-E-E-JIAO CO.,LTD.	+40.09%	6.3B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.34%	4.53B
TASLY PHARMACEUTICAL GROUP CO., LTD	-7.11%	3.29B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.18%	2.63B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.93%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.15%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.67%	1.69B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.73%	1.64B

Alternative Medicine